In NAFLD, for instance, over-expression of AFABP in Kupffer cells of the liver induced non-alcoholic steatohepatitis in mice, while obesity-induced liver injury was alleviated by pharmacological inhibition of AFABP (93). The gene discussed is FABP4; the disease is obesity due to melanocortin 4 receptor deficiency.